Edition:
United Kingdom

People: Evolent Health Inc (EVH.N)

EVH.N on New York Stock Exchange

19.20USD
14 Dec 2018
Change (% chg)

$-0.61 (-3.08%)
Prev Close
$19.81
Open
$19.36
Day's High
$19.92
Day's Low
$18.75
Volume
372,639
Avg. Vol
190,993
52-wk High
$29.00
52-wk Low
$12.30

McGrane, Nicholas 

Mr. Nicholas P. McGrane is Chief Financial Officer of the Company. He has served as our Chief Financial Officer since October 2014. Prior to joining Evolent, Mr. McGrane was Managing Director with Riverside Management Group from July 2013 to October 2014. Prior to joining Riverside Management Group, Mr. McGrane was an independent consultant for clients including Evolent Health LLC. He served as Interim Chief Executive Officer and Interim President of Sbarro Inc. from July 2010 to February 2012. Sbarro Inc. was a portfolio company of MidOcean Partners, where Mr. McGrane held various roles, including Managing Director, from 1997 to 2012. Mr. McGrane holds a bachelor of science degree in management from Trinity College Dublin and a master of business administration from Harvard Business School.

Basic Compensation

Total Annual Compensation, USD 506,250
Restricted Stock Award, USD 312,500
Long-Term Incentive Plans, USD --
All Other, USD 323,300
Fiscal Year Total, USD 1,142,050

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 69,177 1,432,760.00
Name Fiscal Year Total

Frank Williams

3,160,800

Seth Blackley

2,110,800

Nicholas McGrane

1,142,050

Thomas Peterson

1,017,050

Charles Pomeroy

--

Lydia Stone

--
As Of  31 Dec 2017